OBJECTIVES: The survival rate of thalassemia patients has not been conclusively established, and the factors associated with survival remain unclear. This study aimed to determine the survival rate of thalassemia among patients in southern Iran and to identify the factors associated with mortality from thalassemia. METHODS: This retrospective cohort study was conducted based on a retrospective review of the medical re-cords of 911 beta-thalassemia patients in 2014. Data analysis was conducted using the Kaplan-Meier method and Cox regression analysis. RESULTS: Overall, 212 patients (23.3%) died, and 26.8 % had thalassemia intermedia. The 20-year, 40-year, and 60-year survival rates were 85%, 63%, and 54%, respectively. Both crude and adjuste...
Multiple risk factors contribute to cognitive impairment in children with b-thalassemia major. For a...
Introduction: COVID-19 is a major pandemic that is leading cause of morbidity and mortality in the p...
Background With modern medical management, thalassemia major is now extending into adulthood and it ...
OBJECTIVES: The survival rate of thalassemia patients has not been conclusively established, and the...
Background: There currently is a lack of knowledge about the long-term survival of patients with bet...
Background: There currently is a lack of knowledge about the long-term survival of patients with bet...
Background: There is currently lack of knowledge about survival trend analysis of thalassemia patien...
OBJECTIVES Thalassemia is a common genetic disease in Iran, especially in the north and south of Ira...
Background: Iran is a country located on the thalassemic belt of the globe. Investigating such issue...
Objectives: In this trial, our purpose was to determine the distribution of blood groups in Tokat re...
The life expectancy of patients with thalassemia major has significantly increased in recent years, ...
Background: Heart disease is the main cause of mortality and morbidity in patients with beta thalass...
Background Beta-thalassemia is a common hereditary hemoglobinopathy, which is a reason of microcytic...
Competing interests: The authors have declared that no competing interests exist. Abstract. Backgrou...
Background and Objectives: Regular blood transfusions in patients with hereditary hemolytic anemia, ...
Multiple risk factors contribute to cognitive impairment in children with b-thalassemia major. For a...
Introduction: COVID-19 is a major pandemic that is leading cause of morbidity and mortality in the p...
Background With modern medical management, thalassemia major is now extending into adulthood and it ...
OBJECTIVES: The survival rate of thalassemia patients has not been conclusively established, and the...
Background: There currently is a lack of knowledge about the long-term survival of patients with bet...
Background: There currently is a lack of knowledge about the long-term survival of patients with bet...
Background: There is currently lack of knowledge about survival trend analysis of thalassemia patien...
OBJECTIVES Thalassemia is a common genetic disease in Iran, especially in the north and south of Ira...
Background: Iran is a country located on the thalassemic belt of the globe. Investigating such issue...
Objectives: In this trial, our purpose was to determine the distribution of blood groups in Tokat re...
The life expectancy of patients with thalassemia major has significantly increased in recent years, ...
Background: Heart disease is the main cause of mortality and morbidity in patients with beta thalass...
Background Beta-thalassemia is a common hereditary hemoglobinopathy, which is a reason of microcytic...
Competing interests: The authors have declared that no competing interests exist. Abstract. Backgrou...
Background and Objectives: Regular blood transfusions in patients with hereditary hemolytic anemia, ...
Multiple risk factors contribute to cognitive impairment in children with b-thalassemia major. For a...
Introduction: COVID-19 is a major pandemic that is leading cause of morbidity and mortality in the p...
Background With modern medical management, thalassemia major is now extending into adulthood and it ...